Article

Renal transplant patient with polyoma virus bladder infection and subsequent polyoma virus nephropathy.

Department of Pathology, Mount Sinai School of Medicine, New York 10029, USA.
International Journal of Urology (Impact Factor: 1.73). 05/2006; 13(4):439-41. DOI: 10.1111/j.1442-2042.2006.01337.x
Source: PubMed

ABSTRACT Polyoma virus nephropathy (PVN) is a significant cause of renal allograft dysfunction in transplant patients. A 58-year-old male received a cadaveric renal transplant and 12 weeks later presented with fever, diarrhea, and dysuria. He was diagnosed with a polyoma virus infection of the bladder by a transurethral bladder biopsy. One year post-transplant, he presented with renal allograft dysfunction and was diagnosed by biopsy with PVN of the non-native kidney. The diagnosis of a polyoma virus infection was confirmed by immunoreactivity to the polyoma T-antigen. We suggest that polyoma virus infection of the bladder be included in the differential diagnosis of urinary dysfunction in post-transplant patients, as such infections might be an under-recognized comorbidity in individuals with PVN.

0 Bookmarks
 · 
52 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Many infections can affect immunosuppressed renal allograft recipients either as systemic events or organ limited diseases. Some infections are restricted to the allograft. Here I will discuss the most important, clinically and diagnostically challenging productive viral infections found in kidney transplants. Table 1 lists helpful diagnostic clues when evaluating allograft biopsies.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dysfunction of the urinary bladder is often faced in kidney transplantation due to various structural, neurological, infectious, or other pathologies. As the goal is to obtain a well functioning urinary bladder or at least, a low-pressure reservoir without reflux, specific urologic examinations and therapies should be performed. This review based on a Medline and PubMed search as well as on international guidelines and personal experience, reflects the actual knowledge in the field of pretransplant urologic evaluation as well as pre- and posttransplant optimal therapeutic options. The evaluation of these factors and interventional strategies will help to improve long-term transplant outcomes.
    Transplantation Proceedings 01/2011; 43(1):387-90. · 0.95 Impact Factor